✦ LIBER ✦

Comparison of aminoglutethimide and ketoconazole as second line treatments in patients with advanced prostatic cancer

✍ Scribed by Robin Murray; Mark Cooper; Paula Pitt

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Taxol as Second-Line Treatment in Patien

✍ K. Mayerhofer; E. Kucera; H. Zeisler; P. Speiser; A. Reinthaller; P. Sevelda 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Docetaxel and oxaliplatin combination in

✍ Carlo Barone; Michele Basso; Giovanni Schinzari; Carmelo Pozzo; Nunziatina Trigi 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 200 KB

0-72. Rivizor® versus aminoglutethimide

✍ S.J. Houston 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 300 KB

A Phase 2 Study with Epirubicin as Secon

✍ Hanne Havsteen; Kamma Bertelsen; Carl C. Gadeberg; Anders Jacobsen; Claus Kamby; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Advanced (>second) line chemotherapy in

✍ Bruchim, Ilan; Jarchowsky-Dolberg, Osnat; Fishman, Ami 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 411 KB

Cisplatin and irinotecan (CPT-11) as sec

✍ Kakolyris, S; Kouroussis, Ch; Souglakos, J; Agelaki, S; Kalbakis, K; Vardakis, N 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 79 KB